The potential of microrobots is enormous. These miniature objects can be designed to carry out actions within the body, such as sensing biomarkers, manipulating objects like blood clots, or delivering drug therapies to tumor sites. But working out how to make the tiny bots effective, biocompatible, and cost effective is challenging. Now a Caltech-led team has taken a huge step toward making the next generation of microrobots for drug delivery. They have simplified both the structure of the microrobots and their production method, while making the bots highly effective and "smart" enough to direct themselves to a tumor.
